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Summary
This review was conducted as a complementary study to our review “Current concepts in the 
treatment of cartilage damage. A review”, in this same Journal, on promising new strategies in 
the treatment of cartilage defects. The established treatments such as osteochondral implants, 
bone marrow stimulation techniques and chondrogeneic cell implantations, besides advan-
tages, have drawbacks that have led to seek new strategies such as scaffold materials. Matrix-
associated chondrocyte implantation, hyaluronan-based scaffolds, tissue-engineered collagen 
matrices seeded with autologous chondrocytes and encapsulation of autologous chondrocytes 
in poly(ethylene glycol) diacrylate (PEGDA) seem to be less invasive and have a good perfor-
mance. In this review we describe benefits and disadvantages of the new procedures of carti-
lage regeneration by scaffolding materials such as PEGDA.
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Introduction
Cartilage is a flexible connective tissue found in many areas of human and oth-
er animal bodies, including joints between bones. It is composed of specialized cells 
called chondroblasts and chondrocytes that produce a large amount of extracellular 
matrix composed of collagen fibers and abundant ground substance, rich in proteo-
glycan and elastin fibers (Musumeci, 2013a). According to the amount of these com-
ponents cartilage is classified in three types: elastic cartilage, hyaline cartilage and 
fibrocartilage. Unlike other connective tissues, cartilage does not contain blood ves-
sels. The cells that reside in the matrix are called chondrocytes, they are located in 
lacunae within the matrix (forming chondrons together with the pericellular matrix) 
and represent only 5% to 10% of the total cartilage volume but are crucial to the 
maintenance of a stable extra-cellular matrix (Musumeci, 2013b). The chondrocytes 
are supplied by diffusion, helped by the pumping action generated by compression 
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of the articular cartilage or flexion of the elastic cartilage (Musumeci, et al., 2013c; 
Pichler et al., 2013).
Increasing the source of cells for artificial reparation of cartilage defects is becom-
ing an issue. The limited supply of cartilage, as a source of chondrocytes, requires a 
phase of expansion in monolayer culture. Chondrocyte expansion is complicated by 
the fact that monolayer-cultured chondrocytes de-differentiate, lose their characteris-
tic phenotype and synthesize type I rather than type II collagen (Rahfoth et al., 1998). 
This has led to investigation into the use of stem cells. Stem cells can be relatively 
easily harvested and the procedures using stem cells are less invasive or destructive 
than articular cartilage harvesting procedures. The inherent ability of stem cells to 
self-renew opens the possibility that cell expansion may be achievable post-implan-
tation (Wang et al., 2003). The differentiation of stem cells into different cell types is 
reliant on the local microenvironment, and growth factors, extracellular matrix and 
mechanical forces are provided by bioreactors (Wang et al., 2003; Angele et al., 2004; 
Miyanishi et al., 2006). Bioreactors, which apply load, have been frequently used in 
chondrogenic studies. However, the aim of those studies has been to pre-condition 
the implant prior to implantation, mainly by axial loading, which does not reflect the 
complexity of joint motion. The appropriate use of a bioreactor can be to apply load, 
which more closely reproduces the in vivo joint kinematic and would better predict 
what would occur to an implant after implantation into a defect. Thus by specifical-
ly employing such a bioreactor system as an intermediate step prior to animal stud-
ies we can screen new repair techniques under stimulated in vivo conditions. In this 
review we describe benefits and disadvantages of the new procedures of cartilage 
regeneration by scaffolding materials such as PEGDA.
New Perspectives
In view of the problems and drawbacks inherent to all long established techniques 
(see accompanying review in this same issue) we will refer to the encouraging hypoth-
esis, stemming out of different studies, that a novel method to improve chondrocytes 
delivery in vivo, their proliferation and cartilage regeneration may be represented by 
encapsulation of autologous chondrocytes in poly(ethylene glycol) diacrylate (PEG-
DA) (Figs 1, 2, 3) to protect the cells from the harsh environment of inflamed joints. 
This method increases the survival rate of chondrocytes while they are slowly being 
released from encapsulation and incorporated into new cartilage tissue.
First of all, chondrocytes should come from mesenchymal stem cells (Fig. 4), 
which differentiate in chondrocyte progenitors. Use of mesenchymal stem cells pro-
vides a renewable source of chondrocytes. It is necessary a minimally-to-non inva-
sive method to isolate mesenchymal stem cells from patient bone marrow or from 
adipose tissue (Musumeci et al., 2011a). Mesenchymal stem cells, in vitro, need to be 
cultured, to grow and differentiate into chondrocytes. After their isolation, the mes-
enchymal stem cells are expanded on a matrix of polyethylene oxide, chitin and chi-
tosan in standard culture medium. Optimized levels of chondrogenesis have been 
achieved using a scaffold composed of 30% polyethylene oxide, 20% chitin and 40% 
chitosan (Kuo and Ku, 2008). This step is necessary because cartilage repair tech-
niques require a certain amount of healthy native cartilage (Wright, 2009). In order 
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to differentiate the mesenchymal stem cells into chondrocytes, they are pretreated 
with transforming growth factor-β1 (TGF- β 1), necessary for chondrocyte differen-
tiation, followed by insulin-like growth factor-1 (IGF-1) that increases extra-cellular 
matrix production and deposition by the cells (Worster et al., 2001). Cultured chon-
drocytes can be harvested from the polyethylene oxide/chitin/chitosan matrix using 
an established procedure involving incubation with collagenase and fetal bovine 
serum (Musumeci et al., 2011b). Chondrocytes derived from these mesenchymal 
stem cells should be encapsulated and characterized. The harvested chondrocytes 
are then suspended in a PEGDA solution in sterile PBS with penicillin and strepto-
mycin. After encapsulation of autologous chondrocytes in PEGDA, in vitro tests are 
required to verify if these cells are able to survive better than non-encapsulated cells 
when exposed to inflammatory conditions similar to those found in a degenerating 
articular cartilage. After injury, cell apoptosis and inflammation lead to a very toxic 
local environment that adversely affects cell proliferation and survival. By encapsu-
lating these chondrocytes, the cells are better able to resist the harsher environment. 
While in vitro encapsulation promotes survival, the in vivo and long-term efficacy of 
this treatment is unknown, given the different chemical and mechanical loading con-
ditions. It is also unknown if matrix remodeling is able to clear the PEGDA from 
the wound area once the chondrocytes have proliferated to an acceptable degree. 
Figure 1 – Diagram of encapsulation of cartilage cells in hydrogel.
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Figure 2 – In this figure the chondrocytes into the Hydrogel PEGDA scaffold are shown since 0 day to 1 
month culture. Notice the difference in size between the hydrogel scaffold at 3 weeks of encapsulation and 
after 1 month. This suggests that there is cellular growth in the hydrogel as confirmed by histology (increase 
in proliferation, cellular aggregations in nests, typical structures of the hyaline cartilage, and an increase in 
ECM production), described in details in our recent study (Musumeci et al., 2011b). A) day 0. B) 1 week. C) 2 
weeks. D) 3 weeks. E) 1 month.
Figure 3 – New hyaline cartilage after 1 month encapsulation in a hydrogel (PEGDA) scaffold. (A) Haema-
toxylin and eosin. (B) Alcian blue. (C) Safranin-O. Original magnification x20.
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The feasibility of long term in vivo survivability and effectiveness should be further 
investigated. Check tests to extrapolate properties of the tissue in vivo are necessary, 
so it is fundamental to evaluate some parameters such as measuring cell viability, 
apoptosis (Musumeci et al., 2011b), β-Defensin-4 (Musumeci et al., 2012), lubricin 
(Musumeci et al., 2011c), mechanical properties (Julkunen et al., 2008) and biochemi-
cal composition (Suh and Matthew, 2000). Also, histological analysis is required to 
assess the health of the implanted tissues, encapsulated versus non-encapsulated, 
and additional tests may be applied to check for the degradation of PEGDA encap-
sulation (Musumeci et al., 2011c). At last, it remains to check the long-term survival 
of the product. The advantages of this treatment method consist in its relative flex-
ibility and minimally invasive nature. Furthermore, the time length of about two 
months is acceptable clinically. The drawbacks of this treatment are that it may not 
be successful for an autoimmune disorder like rheumatoid arthritis and that there is 
not yet much evidence to suggest that the encapsulated cells have the same mechan-
ical properties of native chondrocytes. It is not possible to predict if the patient will 
regain full motion and quality of life. However recent data support this new tech-
nique (Musumeci et al., 2011c; Musumeci et al., 2011b), and results of these studies 
suggest the possibility of applying autologous cell transplantation in conjunction 
with scaffold materials for repairing cartilage lesions in patients with osteoarthritis 
to reduce at least the progression of the disease. 
Figure 4 – Diagram of possible differentiation pathways of bone marrow derived mesenchymal stem cells 
(MSCs).
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Conclusion
Cell-based techniques performed with or without a scaffold have demonstrated 
good results in animal and basic-science models such as bioreactor, but further in 
vivo and in vitro studies must be carried out in order to confirm their successful clin-
ical outcomes.
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